Alpha Wave Global, LP Atai Life Sciences N.V. Transaction History

Alpha Wave Global, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.82 - $17.8 $2.71 Million - $7.08 Million	-397,855 Reduced 15.71%	2,134,625 $16.3 Million
Q3 2021 Nov 12, 2021	SELL	$13.62 - $19.48 $1.28 Million - $1.83 Million	-93,993 Reduced 3.58%	2,532,480 $37.5 Million
Q2 2021 Aug 13, 2021	BUY	$16.94 - $19.89 $44.5 Million - $52.2 Million	2,626,473 New	2,626,473 $48.6 Million

12.4M

77.8K

50.3K

Ticker ATAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 165,875,008
Market Cap $197M
Description
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...

Get notified when there are updates to the investment portfolio of Alpha Wave Global, LP, based on Form 13F filings with the SEC.

Stay updated on Alpha Wave Global, LP with notifications on news.